Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone
暂无分享,去创建一个
[1] M. Polak,et al. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences , 2017, Clinical chemistry and laboratory medicine.
[2] F. Distelmaier,et al. Biotin Treatment Mimicking Graves' Disease. , 2016, The New England journal of medicine.
[3] D. Mock,et al. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis , 2016, Expert opinion on drug metabolism & toxicology.
[4] H. Fatemi,et al. Significance of premature progesterone rise in IVF , 2015, Current opinion in obstetrics & gynecology.
[5] D. Galanaud,et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. , 2015, Multiple sclerosis and related disorders.
[6] Aaron A. Alford,et al. Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review. , 2015, Clinical biochemistry.
[7] M. Baumgartner,et al. Biotin-responsive Disorders , 2006 .
[8] M. Baumgartner,et al. Inborn Metabolic Diseases , 1995, Springer Berlin Heidelberg.